Umbilical cord blood stem cells had used for the treatment of a blind girl, who was born with congenital dysplasia of the optic nerve.
18 months old blind girl, who was born with congenital dysplasia of the optic nerve reacted to flashlight for the first time, after serial treatments with cord blood stem cells. The family of the little Summer exhausted all the possible treatments in USA and also had been informed about a controversial cell therapy, that take place in a hospital in Peking China. The family sought the treatment in China after they were told by American ophthalmologists that nothing could be done to correct Summers blindness. The family finally decided to travel to China and Summer received this treatment. Summer took eight stem-cell treatments from umbilical-cord blood during her 33-day stay in a Chinese hospital. Halfway through her stem-cell treatments, Summer was taken into a dark bathroom where a doctor shone a flashlight. Summer followed the ray of light with her eyes, something shed never done. Her family hopes the treatments will grow her optic nerve, which didnt develop on its own, and cure the rare disorder from which she suffers: septo-optic dysplasia. Doctors in China told the family it can take up to a year for the cells to do their work. Most improvements probably will come in nine months, they said. The company hasnt submitted to clinical trials, and the treatments are not approved in the United States. In the same medical centre 4000 patients with with multiple sclerosis and autism had been treated until today with improvement in 90% of them.
AABB SMART January 2010